Moderna's MRNA Win Weakens Patent Pledges
Moderna's win over Pfizer and BioNTech in a U.K. dispute over mRNA patents could undermine increasingly popular pledges not to enforce patents, intellectual property experts say, after a London court held...To view the full article, register now.
Already a subscriber? Click here to view full article